The Link between Fetal Programming, Inflammation, Muscular Strength, and Blood Pressure

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Lopez Lopez, Jose ^a   Lopez Jaramillo, Patricio ^a,b   Camacho, Paul A ^a,c   Gomez Arbelaez, Diego ^b,d   Cohen, Daniel D ^a,b  

^a Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

^b UNIVERSIDAD DE SANTANDER   (Colombia)

^c UNIVERSIDAD AUTÓNOMA DE BUCARAMANGA   (Colombia)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL OBESITY; ADULTHOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; FETUS DEVELOPMENT; HUMAN; INFLAMMATION; LOW BIRTH WEIGHT; MALNUTRITION; MATERNAL OBESITY; METABOLIC DISORDER; MUSCLE STRENGTH; NONHUMAN; NUTRITION; PROGENY; REVIEW; RISK FACTOR; ADIPOCYTE; ADULT; CHILD; CYTOLOGY; FEMALE; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MALE; OBESITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SKELETAL MUSCLE;

ADIPOCYTES; ADIPOSITY; ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; FEMALE; FETAL DEVELOPMENT; HUMANS; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIFE STYLE; MALE; METABOLIC DISEASES; MUSCLE, SKELETAL; OBESITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK FACTORS;

EID: 84944254747     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/710613     Document Type: Review

References (74)

1. M. M. Ibrahim and A. Damasceno, "Hypertension in developing countries," The Lancet, vol. 380, no. 9841, pp. 611-619, 2012
2. World Health Organization, Obesity and Overweight, WHO, Geneva, Switzerland, 2012, http://www. who. int/mediacentre/ factsheets/fs311/en/print. html
3. World Health Organization, Global Status Report on Noncommunicable Diseases, World Health Organization, Geneva, Switzerland, 2010
4. C. K. Chow, K. K. Teo, S. Rangarajan et al., "Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries," Journal of the AmericanMedical Association, vol. 310, no. 9, pp. 959-968, 2013
5. V. Perkovic, R. Huxley, Y. Wu, D. Prabhakaran, and S. MacMahon, "The burden of blood pressure-related disease: a neglected priority for global health," Hypertension, vol. 50, no. 6, pp. 991-997, 2007
6. S. K. Bhargava, H. S. Sachdev, C. H. D. Fall et al., "Relation of serial changes in childhood body-mass index to impaired glucose tolerance in young adulthood," The New England Journal of Medicine, vol. 350, no. 9, pp. 865-875, 2004
7. S. Galic, J. S. Oakhill, and G. R. Steinberg, "Adipose tissue as an endocrine organ,"Molecular and Cellular Endocrinology, vol. 316, no. 2, pp. 129-139, 2010
8. V. Lahera, C. F. Rueda-Clausen, P. Lopez-Jaramillo, C. Luengas, M. D. P. Oubiña, and V. Cachofeiro, "Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects," Mediators of Inflammation, vol. 2009, Article ID 469169, 8 pages, 2009
9. R. Ross, "Atherosclerosis-an inflammatory disease," The New England Journal of Medicine, vol. 340, no. 2, pp. 115-126, 1999
10. L. E. Bautista, P. López-Jaramillo, L. M. Vera, J. P. Casas, A. P. Otero, and A. I. Guaracao, "Is C-reactive protein an independent risk factor for essential hypertension" Journal of Hypertension, vol. 19, no. 5, pp. 857-861, 2001
11. H. D. Sesso, J. E. Buring, N. Rifai, G. J. Blake, J. M. Gaziano, and P. M. Ridker, "C-reactive protein and the risk of developing hypertension,"The Journal of theAmericanMedical Association, vol. 290, no. 22, pp. 2945-2951, 2003
12. E. Teran, C. Escudero, W. Moya, M. Flores, P. Vallance, and P. Lopez-Jaramillo, "Elevated C-reactive protein and proinflammatory cytokines in Andean women with preeclampsia," International Journal of Gynecology and Obstetrics, vol. 75, no. 3, pp. 243-249, 2001
13. Y. Ding, S. Li, R.-L. Ma et al., "Association of homeostasismodel assessment of insulin resistance, adiponectin, and low-grade inflammation with the course of the metabolic syndrome," Clinical Biochemistry, vol. 48, no. 7-8, pp. 503-507, 2015
14. P. López-Jaramillo, E. Herrera, R. G. Garcia, P. A. Camacho, and V. R. Castillo, "Inter-relationships between body mass index, C-reactive protein and blood pressure in a hispanic pediatric population," American Journal ofHypertension, vol. 21,no. 5, pp. 527-532, 2008
15. D. G. Cook, M. A. Mendall, P. H. Whincup et al., "C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors," Atherosclerosis, vol. 149, no. 1, pp. 139-150, 2000
16. E. S. Ford, "C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000," Circulation, vol. 108, no. 9, pp. 1053-1058, 2003
17. P. López-Jaramillo, C. Velandia-Carrillo, J. Álvarez-Camacho, D. D. Cohen, T. Sánchez-Solano, and G. Castillo-López, "Inflammation and hypertension: are there regional differences" International Journal of Hypertension, vol. 2013, Article ID 492094, 12 pages, 2013
18. C. F. Rueda-Clausen, V. Lahera, J. Calderón et al., "The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors," International Journal of Cardiology, vol. 139, no. 1, pp. 32-41, 2010
19. K. A. M. Jandeleit-Dahm, C. Tikellis, C. M. Reid, C. I. Johnston, and M. E. Cooper, "Why blockade of the renin-angiotensin system reduces the incidence of new-onset diabetes," Journal of Hypertension, vol. 23, no. 3, pp. 463-473, 2005
20. N. de las Heras, B. Martín-Fernández, M. Miana et al., "The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance," Journal of Hypertension, vol. 27, no. 6, pp. S37-S41, 2009
21. S. Otabe, X. Yuan, T. Fukutani et al., "Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet," The American Journal of Physiology- Endocrinology and Metabolism, vol. 293, no. 1, pp. E210-E218, 2007
22. M. Ryo, T. Nakamura, S. Kihara et al., "Adiponectin as a biomarker of the metabolic syndrome," Circulation Journal, vol. 68, no. 11, pp. 975-981, 2004
23. N. Soebijanto and S. Waspadji, "Adiponectin levels and its role in insulin resistance among adult women with metabolic syndrome," Acta Medica Indonesiana, vol. 42, no. 4, pp. 187-191, 2010
24. A. Onat, G. Hergenç, G. Can, and Z. Küçükdurmaz, "Serum adiponectin confers little protection against diabetes and hypertension in Turkish men," Obesity, vol. 17, no. 3, pp. 564-570, 2009
25. J. Hung, B. M. McQuillan, P. L. Thompson, and J. P. Beilby, "Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity," International Journal of Obesity, vol. 32, no. 5, pp. 772-779, 2008
26. M.-H. Gannagé-Yared, S. Khalife, M. Semaan, F. Fares, S. Jambart, and G. Halaby, "Serum adiponectin and leptin levels in relation to the metabolic syndrome, and rogenic profile and somatotropic axis in healthy non-diabetic elderly men," European Journal of Endocrinology, vol. 155, no. 1, pp. 167-176, 2006
27. T. Kelly, W. Yang, C.-S. Chen, K. Reynolds, and J. He, "Global burden of obesity in 2005 and projections to 2030," International Journal of Obesity, vol. 32, no. 9, pp. 1431-1437, 2008
28. A. Cuevas, V. Alvarez, and F. Carrasco, "Epidemic of metabolic syndrome in Latin America," Current Opinion in Endocrinology, Diabetes and Obesity, vol. 18, no. 2, pp. 134-138, 2011
29. A. Cuevas, V. Alvarez, and C. Olivos, "The emerging obesity problem in Latin America," Expert Review of Cardiovascular Therapy, vol. 7, no. 3, pp. 281-288, 2009
30. C. M. Doak, L. S. Adair, M. Bentley, C. Monteiro, and B. M. Popkin, "The dual burden household and the nutrition transition paradox," International Journal of Obesity, vol. 29, no. 1, pp. 129-136, 2005
31. D. J. P. Barker and C. N. Martyn, "The maternal and fetal origins of cardiovascular disease," Journal of Epidemiology and Community Health, vol. 46, no. 1, pp. 8-11, 1992
32. L. S. Adair and T. J. Cole, "Rapid child growth raises blood pressure in adolescent boys who were thin at birth," Hypertension, vol. 41, no. 3 I, pp. 451-456, 2003
33. K. Szarc vel Szic, M. N. Ndlovu, G. Haegeman, and W. Vanden Berghe, "Nature or nurture: let food be your epigeneticmedicine in chronic inflammatory disorders," Biochemical Pharmacology, vol. 80, no. 12, pp. 1816-1832, 2010
34. R. C. Painter, C. Osmond, P. Gluckman, M. Hanson, D. I. W. Phillips, and T. J. Roseboom, "Transgenerational effects of prenatal exposure to the Dutch famine on neonatal adiposity and health in later life," BJOG, vol. 115, no. 10, pp. 1243-1249, 2008
35. T. Roseboom, S. de Rooij, and R. Painter, "The dutch famine and its long-term consequences for adult health," Early Human Development, vol. 82, no. 8, pp. 485-491, 2006
36. A. Snoeck, C. Remacle, B. Reusens, and J. J. Hoet, "Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas," Biology of the Neonate, vol. 57,no. 2, pp. 107-118, 1990
37. S. Dahri, A. Snoeck, B. Reusens-Billen, C. Remacle, and J. J. Hoet, "Islet function in offspring ofmothers on low-protein diet during gestation," Diabetes, vol. 40, supplement 2, pp. 115-120, 1991
38. C. N. Hales, D. J. P. Barker, P. M. S. Clark et al., "Fetal and infant growth and impaired glucose tolerance at age 64," The British Medical Journal, vol. 303, no. 6809, pp. 1019-1022, 1991
39. M. C. P. Franco, D. E. Casarini, M. S. Carneiro-Ramos, A. L. Sawaya, M. L. M. Barreto-Chaves, and R. Sesso, "Circulating renin-angiotensin system and catecholamines in childhood: is there a role for birthweight" Clinical Science, vol. 114, no. 5-6, pp. 375-380, 2008
40. E. G. Artero, J. R. Ruiz, F. B. Ortega et al., "Muscular and cardiorespiratory fitness are independently associated with metabolic risk in adolescents: the HELENA study," Pediatric Diabetes, vol. 12, no. 8, pp. 704-712, 2011
41. J. Steene-Johannessen, S. A. Anderssen, E. Kolle, and L. B. Andersen, "Lowmuscle fitness is associated withmetabolic risk in youth,"Medicine & Science in Sports & Exercise, vol. 41, no. 7, pp. 1361-1367, 2009
42. F. B. Ortega, K. Silventoinen, P. Tynelius, and F. Rasmussen, "Muscular strength in male adolescents and premature death: cohort study of one million participants," The British Medical Journal, vol. 345, Article IDe7279, 2012
43. J. R. Ruiz, X. Sui, F. Lobelo et al., "Association betweenmuscular strength and mortality in men: prospective cohort study," The British Medical Journal, vol. 337, article a439, 2008
44. E. G. Artero, D.-C. Lee, J. R. Ruiz et al., "A prospective study of muscular strength and all-cause mortality in men with hypertension," Journal of the American College of Cardiology, vol. 57, no. 18, pp. 1831-1837, 2011
45. P. Lopez-Jaramillo, D. D. Cohen, D. Gómez-Arbeláez et al., "Association of handgrip strength to cardiovascularmortality in pre-diabetic and diabetic patients: a subanalysis of the ORIGIN trial," International Journal ofCardiology, vol. 174, no. 2,pp. 458-461, 2014
46. J. P. Loenneke, C. A. Fahs, K. S. Heffernan, L. M. Rossow, R. S. Thiebaud, and M. G. Bemben, "Relationship between thigh muscle mass and augmented pressure from wave reflections in healthy adults," European Journal of Applied Physiology, vol. 113, no. 2, pp. 395-401, 2013
47. C. A. Fahs, K. S. Heffernan, S. Ranadive, S. Y. Jae, and B. Fernhall, "Muscular strength is inversely associated with aortic stiffness in youngmen,"Medicine&Science in Sports&Exercise, vol. 42, no. 9, pp. 1619-1624, 2010
48. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg et al., "Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength," Journals of Gerontology A Biological Sciences and Medical Sciences, vol. 64, no. 11, pp. 1183-1189, 2009
49. J. Steene-Johannessen, E. Kolle, L. B. Andersen, and S. A. Anderssen, "Adiposity, aerobic fitness, muscle fitness, and markers of inflammation in children," Medicine & Science in Sports & Exercise, vol. 45, no. 4, pp. 714-721, 2013
50. E. G. Artero, V. España-Romero, D. Jiménez-Pavón et al., "Muscular fitness, fatness and inflammatory biomarkers in adolescents," Pediatric Obesity, vol. 9, no. 5, pp. 391-400, 2014
51. D. D. Cohen, D. Gómez-Arbeláez, P. A. Camacho et al., "Low muscle strength is associated with metabolic risk factors in Colombian children: the ACFIES Study," PLoS ONE, vol. 9, no. 4, Article ID e93150, 2014
52. T. N. Kim, M. S. Park, J. Y. Ryu et al., "Impact of visceral fat on skeletal muscle mass and vice versa in a prospective cohort study: the Korean Sarcopenic Obesity Study (KSOS)," PLoS ONE, vol. 9, no. 12, Article IDe115407, 2014
53. N. Mathur and B. K. Pedersen, "Exercise as a mean to control low-grade systemic inflammation," Mediators of Inflammation, vol. 2008, Article ID109502, 6 pages, 2008
54. A. M. W. Petersen and B. K. Pedersen, "The anti-inflammatory effect of exercise," Journal of Applied Physiology, vol. 98, no. 4, pp. 1154-1162, 2005
55. S. Balducci, S. Zanuso, A. Nicolucci et al., "Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss," Nutrition, Metabolism and Cardiovascular Diseases, vol. 20, no. 8, pp. 608-617, 2010
56. C. E. Donges, R. Duffield, and E. J. Drinkwater, "Effects of resistance or aerobic exercise training on interleukin-6, Creactive protein, and body composition," Medicine and Science in Sports and Exercise, vol. 42, no. 2, pp. 304-313, 2010
57. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg, and M. Visser, "Inflammatory markers and loss of muscle mass (sarcopenia) and strength," The American Journal of Medicine, vol. 119, no. 6, pp. 526. e9-526. e17, 2006
58. A. Nazmi and C. G. Victora, "Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies," BMC PublicHealth, vol. 7, article 212, 2007
59. J. C. K. Wells, "Maternal capital and the metabolic ghetto: An evolutionary perspective on the transgenerational basis of health inequalities," American Journal of Human Biology, vol. 22, no. 1, pp. 1-17, 2010
60. J. C. K. Wells, S. Chomtho, and M. S. Fewtrell, "Programming of body composition by early growth and nutrition," Proceedings of the Nutrition Society, vol. 66, no. 3, pp. 423-434, 2007
61. C. A. Maltin, "Muscle development and obesity: is there a relationship" Organogenesis, vol. 4, no. 3, pp. 158-169, 2008
62. C. B. Jensen, H. Storgaard, S. Madsbad, E. A. Richter, and A. A. Vaag, "Altered skeletal muscle fiber composition and size precede whole-body insulin resistance in young men with low birth weight," Journal of Clinical Endocrinology and Metabolism, vol. 92, no. 4, pp. 1530-1534, 2007
63. S. E. Ozanne, C. B. Jensen, K. J. Tingey, H. Storgaard, S. Madsbad, and A. A. Vaag, "Low birthweight is associated with specific changes in muscle insulin-signalling protein expression," Diabetologia, vol. 48, no. 3, pp. 547-552, 2005
64. C. B. Jensen, M. S. Martin-Gronert, H. Storgaard, S. Madsbad, A. Vaag, and S. E. Ozanne, "Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight," PLoS ONE, vol. 3, no. 11,Article ID e3738, 2008
65. S. C. Bodine, T. N. Stitt, M. Gonzalez et al., "Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo," Nature Cell Biology, vol. 3, no. 11, pp. 1014-1019, 2001
66. K. Walsh, "Adipokines, myokines and cardiovascular disease," Circulation Journal, vol. 73, no. 1, pp. 13-18, 2009
67. D. Kuh, J. Bassey, R. Hardy, A. A. Sayer, M. Wadsworth, and C. Cooper, "Birth weight, childhood size, and muscle strength in adult life: evidence froma birth cohort study," American Journal of Epidemiology, vol. 156, no. 7, pp. 627-633, 2002
68. A. A. Sayer, H. E. Syddall, H. J. Gilbody, E. M. Dennison, and C. Cooper, "Does sarcopenia originate in early life? Findings from the Hertfordshire cohort study," Journals of Gerontology: A Biological Sciences and Medical Sciences, vol. 59, no. 9, pp. M930-M934, 2004
69. F. B. Ortega, J. R. Ruiz, I. Labayen et al., "High fitness is associated with a healthier programming of body composition at adolescence," American Journal ofHuman Biology, vol. 20,no. 6, pp. 732-734, 2008
70. C. L. Ridgway, K. K. Ong, T. Tammelin, S. J. Sharp, U. Ekelund, and M.-R. Jarvelin, "Birth size, infant weight gain, and motor development influence adult physical performance," Medicine &Science in Sports&Exercise, vol. 41,no. 6, pp. 1212-1221, 2009
71. M. A. Moura-Dos-Santos, M. B. De Almeida, R. Manhães-De-Castro, P. T. Katzmarzyk, J. A. R. Maia, and C. G. Leandro, "Birthweight, body composition, and motor performance in 7-to 10-year-old children," Developmental Medicine & Child Neurology, vol. 57, no. 5, pp. 470-475, 2015
72. C. L. Ridgway, S. Brage, S. Anderssen, L. B. Sardinha, L. B. Andersen, and U. Ekelund, "Fat-free mass mediates the association between birth weight and aerobic fitness in youth," International Journal of Pediatric Obesity, vol. 6, no. 2-2, pp. e590-e596, 2011
73. C. Brøns, C. B. Jensen, H. Storgaard et al., "Mitochondrial function in skeletal muscle is normal and unrelated to insulin action in young men born with low birth weight," Journal of Clinical Endocrinology and Metabolism, vol. 93,no. 10,pp. 3885-3892, 2008
74. J. C. K. Wells, "The thrifty phenotype: an adaptation in growth or metabolism" American Journal of Human Biology, vol. 23, no. 1, pp. 65-75, 2011.